Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2008

01-11-2008 | Article

Involvement of the Helicobacter pylori plasticity region and cag pathogenicity island genes in the development of gastroduodenal diseases

Authors: A. R. Pacheco, J. L. Proença-Módena, A. I. L. Sales, Y. Fukuhara, W. D. da Silveira, J. L. Pimenta-Módena, R. B. de Oliveira, M. Brocchi

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2008

Login to get access

Abstract

Infection by Helicobacter pylori is associated with the development of several gastroduodenal diseases, including gastritis, peptic ulcer disease (gastric ulcers and duodenal ulcers), and gastric adenocarcinoma. Although a number of putative virulence factors have been reported for H. pylori, there are conflicting results regarding their association with specific H. pylori-related diseases. In this work, we investigated the presence of virB11 and cagT, located in the left half of the cag pathogenicity island (cagPAI), and the jhp917jhp918 sequences, components of the dupA gene located in the plasticity zone of H. pylori, in Brazilian isolates of H. pylori. We also examined the association between these genes and H. pylori-related gastritis, peptic ulcer disease, and gastric and duodenal ulcers in an attempt to identify a gene marker for clinical outcomes related to infection by H. pylori. The cagT gene was associated with peptic ulcer disease and gastric ulcers, whereas the virB11 gene was detected in nearly all of the samples. The dupA gene was not associated with duodenal ulcers or any gastroduodenal disease here analyzed. These results suggest that cagT could be a useful prognostic marker for the development of peptic ulcer disease in the state of São Paulo, Brazil. They also indicate that cagT is associated with greater virulence and peptic ulceration, and that this gene is an essential component of the type IV secretion system of H. pylori.
Literature
1.
go back to reference Suerbaum S, Josenhans C (2007) Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol 5:441–452PubMedCrossRef Suerbaum S, Josenhans C (2007) Helicobacter pylori evolution and phenotypic diversification in a changing host. Nat Rev Microbiol 5:441–452PubMedCrossRef
2.
go back to reference Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328–1333PubMedCrossRef Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R (1999) Helicobacter pylori virulence and genetic geography. Science 284:1328–1333PubMedCrossRef
3.
go back to reference Proença-Módena JL, Sales AIL, Acrani GO, Russo R, Ribeiro MAV, Fukuhara Y, da Silveira WD, Pimenta-Módena JL, de Oliveira RB, Brocchi M (2007) Association between Helicobacter pylori genotypes and gastric disorders in relation to the cag pathogenicity island. Diagn Microbiol Infect Dis 59:7–16PubMedCrossRef Proença-Módena JL, Sales AIL, Acrani GO, Russo R, Ribeiro MAV, Fukuhara Y, da Silveira WD, Pimenta-Módena JL, de Oliveira RB, Brocchi M (2007) Association between Helicobacter pylori genotypes and gastric disorders in relation to the cag pathogenicity island. Diagn Microbiol Infect Dis 59:7–16PubMedCrossRef
4.
go back to reference Blaser MJ, Atherton JC (2004) Helicobacter pylori persistence: biology and disease. J Clin Invest 113:321–333PubMed Blaser MJ, Atherton JC (2004) Helicobacter pylori persistence: biology and disease. J Clin Invest 113:321–333PubMed
5.
go back to reference Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acd Sci USA 93:14648–14653CrossRef Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acd Sci USA 93:14648–14653CrossRef
6.
go back to reference Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497–1500PubMedCrossRef Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000) Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497–1500PubMedCrossRef
7.
go back to reference Fischer W, Püls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R (2001) Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42:1337–1348PubMedCrossRef Fischer W, Püls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R (2001) Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 42:1337–1348PubMedCrossRef
8.
go back to reference Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S (2003) The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J 22:515–528PubMedCrossRef Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S (2003) The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J 22:515–528PubMedCrossRef
9.
go back to reference Ramarao B, Gray-Owen SD, Backert S, Meyer TF (2000) Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol Microbiol 37:1389–1404PubMedCrossRef Ramarao B, Gray-Owen SD, Backert S, Meyer TF (2000) Helicobacter pylori inhibits phagocytosis by professional phagocytes involving type IV secretion components. Mol Microbiol 37:1389–1404PubMedCrossRef
10.
go back to reference Proença-Módena JL, Acrani GO, Micas AFD, Castro M, Silveira WD, Pimenta-Módena JL, de Oliveira RB, Brocchi M (2007) Correlation between Helicobacter pylori infection, gastric diseases and life habits among patients treated at a university hospital in Southeast Brazil. Braz J Infect Dis 11:89–95 Proença-Módena JL, Acrani GO, Micas AFD, Castro M, Silveira WD, Pimenta-Módena JL, de Oliveira RB, Brocchi M (2007) Correlation between Helicobacter pylori infection, gastric diseases and life habits among patients treated at a university hospital in Southeast Brazil. Braz J Infect Dis 11:89–95
11.
go back to reference Mattar R, Marques SB, Monteiro Mdo S, Dos Santos AF, Iriya K, Carrilho FJ (2007) Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. J Med Microbiol 56:9–14PubMedCrossRef Mattar R, Marques SB, Monteiro Mdo S, Dos Santos AF, Iriya K, Carrilho FJ (2007) Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil. J Med Microbiol 56:9–14PubMedCrossRef
12.
go back to reference Santos A, Queiroz DMM, Ménard A, Marais A, Rocha GA, Oliveira CA, Nogueira AMMF, Uzeda M, Mégraud F (2003) New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J Clin Microbiol 41:1651–1655PubMedCrossRef Santos A, Queiroz DMM, Ménard A, Marais A, Rocha GA, Oliveira CA, Nogueira AMMF, Uzeda M, Mégraud F (2003) New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J Clin Microbiol 41:1651–1655PubMedCrossRef
13.
go back to reference de Jonge R, Kuipers EJ, Langeveld SC, Loffeld RJ, Stoof J, van Vliet AH, Kusters JG (2004) The Helicobacter pylori plasticity region locus jhp0947–jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol Med Microbiol 41:161–167PubMedCrossRef de Jonge R, Kuipers EJ, Langeveld SC, Loffeld RJ, Stoof J, van Vliet AH, Kusters JG (2004) The Helicobacter pylori plasticity region locus jhp0947–jhp0949 is associated with duodenal ulcer disease and interleukin-12 production in monocyte cells. FEMS Immunol Med Microbiol 41:161–167PubMedCrossRef
14.
go back to reference Lu H, Hsu PI, Graham DY, Yamaoka Y (2005) Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128:833–848PubMedCrossRef Lu H, Hsu PI, Graham DY, Yamaoka Y (2005) Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 128:833–848PubMedCrossRef
15.
go back to reference Argent RH, Burette A, Miendje Deyi VY, Atherton JC (2007) The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin Infect Dis 45:1204–1206PubMedCrossRef Argent RH, Burette A, Miendje Deyi VY, Atherton JC (2007) The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America. Clin Infect Dis 45:1204–1206PubMedCrossRef
16.
go back to reference Gomes LI, Rocha GA, Rocha AM, Soares TF, Oliveira CA, Bittencourt PF, Queiroz DM (2008) Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal diseases in Brazilian patients. Int J Med Microbiol 298:223–230PubMedCrossRef Gomes LI, Rocha GA, Rocha AM, Soares TF, Oliveira CA, Bittencourt PF, Queiroz DM (2008) Lack of association between Helicobacter pylori infection with dupA-positive strains and gastroduodenal diseases in Brazilian patients. Int J Med Microbiol 298:223–230PubMedCrossRef
17.
go back to reference Glupczynski Y (1996) Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing. In: Lee A, Mégraud F (eds) Helicobacter pylori: techniques for clinical diagnosis. WB Saunders, London, UK, pp 17–32 Glupczynski Y (1996) Culture of Helicobacter pylori from gastric biopsies and antimicrobial susceptibility testing. In: Lee A, Mégraud F (eds) Helicobacter pylori: techniques for clinical diagnosis. WB Saunders, London, UK, pp 17–32
18.
go back to reference Brocchi M, Covone MG, Palla E, Galeotti CL (1999) Integration of minitransposons for expression of the Escherichia coli elt genes at a preferred site in Salmonella typhimurium identifies a novel putative fimbrial locus. Arch Microbiol 171:122–126PubMedCrossRef Brocchi M, Covone MG, Palla E, Galeotti CL (1999) Integration of minitransposons for expression of the Escherichia coli elt genes at a preferred site in Salmonella typhimurium identifies a novel putative fimbrial locus. Arch Microbiol 171:122–126PubMedCrossRef
19.
go back to reference Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York, p 999 Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, New York, p 999
20.
go back to reference Hanahan D, Jessee J, Bloom FR (1991) Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol 204:63–113PubMedCrossRef Hanahan D, Jessee J, Bloom FR (1991) Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol 204:63–113PubMedCrossRef
21.
go back to reference Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S (1992) Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 30:192–200PubMed Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S (1992) Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 30:192–200PubMed
22.
go back to reference Tomasini ML, Zanussi S, Sozzi M, Tedeschi R, Basaglia G, De Paoli P (2003) Heterogeneity of cag genotypes in Helicobacter pylori isolates from human biopsy specimens. J Clin Microbiol 41:976–980PubMedCrossRef Tomasini ML, Zanussi S, Sozzi M, Tedeschi R, Basaglia G, De Paoli P (2003) Heterogeneity of cag genotypes in Helicobacter pylori isolates from human biopsy specimens. J Clin Microbiol 41:976–980PubMedCrossRef
23.
go back to reference Ali M, Khan AA, Tiwari SK, Ahmed N, Rao LV, Habibullah CM (2005) Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. World J Gastroenterol 11:6815–6822PubMed Ali M, Khan AA, Tiwari SK, Ahmed N, Rao LV, Habibullah CM (2005) Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. World J Gastroenterol 11:6815–6822PubMed
24.
go back to reference Brocchi M, Vasconcelos ATR, Zaha A (2007) Restriction-modification systems in Mycoplasma spp. Gen Mol Biol 30:236–244 Brocchi M, Vasconcelos ATR, Zaha A (2007) Restriction-modification systems in Mycoplasma spp. Gen Mol Biol 30:236–244
25.
go back to reference Cascales E, Christie PJ (2003) The versatile bacterial type IV secretion systems. Nat Rev Microbiol 1:137–149PubMedCrossRef Cascales E, Christie PJ (2003) The versatile bacterial type IV secretion systems. Nat Rev Microbiol 1:137–149PubMedCrossRef
26.
go back to reference Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E (2005) Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol 59:451–485PubMedCrossRef Christie PJ, Atmakuri K, Krishnamoorthy V, Jakubowski S, Cascales E (2005) Biogenesis, architecture, and function of bacterial type IV secretion systems. Annu Rev Microbiol 59:451–485PubMedCrossRef
27.
go back to reference Kauser F, Hussain MA, Ahmed I, Srinivas S, Devi SM, Majeed AA, Rao KR, Khan AA, Sechi LA, Ahmed N (2005) Comparative genomics of Helicobacter pylori isolates recovered from ulcer disease patients in England. BMC Microbiol 5:32PubMedCrossRef Kauser F, Hussain MA, Ahmed I, Srinivas S, Devi SM, Majeed AA, Rao KR, Khan AA, Sechi LA, Ahmed N (2005) Comparative genomics of Helicobacter pylori isolates recovered from ulcer disease patients in England. BMC Microbiol 5:32PubMedCrossRef
28.
go back to reference Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshidam H, Shiratori Y, Omata M (2001) Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol 8:181–186PubMedCrossRef Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshidam H, Shiratori Y, Omata M (2001) Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol 8:181–186PubMedCrossRef
29.
go back to reference Rohde M, Püls J, Buhrdorf R, Fischer W, Hass R (2003) A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol 49:219–234PubMedCrossRef Rohde M, Püls J, Buhrdorf R, Fischer W, Hass R (2003) A novel sheathed surface organelle of the Helicobacter pylori cag type IV secretion system. Mol Microbiol 49:219–234PubMedCrossRef
30.
go back to reference Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ (1997) Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92–99PubMedCrossRef Atherton JC, Peek RM Jr, Tham KT, Cover TL, Blaser MJ (1997) Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112:92–99PubMedCrossRef
31.
go back to reference Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, Bukanov NO, Drazek ES, Roe BA, Berg DE (1998) Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 28:37–53PubMedCrossRef Akopyants NS, Clifton SW, Kersulyte D, Crabtree JE, Youree BE, Reece CA, Bukanov NO, Drazek ES, Roe BA, Berg DE (1998) Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 28:37–53PubMedCrossRef
32.
go back to reference Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, Shiratori Y, Omata M (1999) Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 44:336–341PubMedCrossRef Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, Shiratori Y, Omata M (1999) Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 44:336–341PubMedCrossRef
33.
go back to reference Blomstergren A, Lundin A, Nilsson C, Engstrand L, Lundeberg J (2004) Comparative analysis of the complete cag pathogenicity island sequence in four Helicobacter pylori isolates. Gene 328:85–93PubMedCrossRef Blomstergren A, Lundin A, Nilsson C, Engstrand L, Lundeberg J (2004) Comparative analysis of the complete cag pathogenicity island sequence in four Helicobacter pylori isolates. Gene 328:85–93PubMedCrossRef
34.
go back to reference Alm RA, Trust TJ (1999) Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes. J Mol Med 77:834–846PubMedCrossRef Alm RA, Trust TJ (1999) Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes. J Mol Med 77:834–846PubMedCrossRef
35.
go back to reference Chanto G, Occhialini A, Gras N, Alm RA, Mégraud F, Marais A (2002) Identification of strain-specific genes located outside the plasticity zone in nine clinical isolates of Helicobacter pylori. Microbiology 148:3671–3680PubMed Chanto G, Occhialini A, Gras N, Alm RA, Mégraud F, Marais A (2002) Identification of strain-specific genes located outside the plasticity zone in nine clinical isolates of Helicobacter pylori. Microbiology 148:3671–3680PubMed
Metadata
Title
Involvement of the Helicobacter pylori plasticity region and cag pathogenicity island genes in the development of gastroduodenal diseases
Authors
A. R. Pacheco
J. L. Proença-Módena
A. I. L. Sales
Y. Fukuhara
W. D. da Silveira
J. L. Pimenta-Módena
R. B. de Oliveira
M. Brocchi
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0549-8

Other articles of this Issue 11/2008

European Journal of Clinical Microbiology & Infectious Diseases 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine